Today, the World Health Organization (WHO) published its first-ever position paper on immunization products to protect ...

New prevention measures for RSV have led to a major drop in hospitalizations among infants, according to a new CDC study.

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

The World Health Organization (WHO) on Friday recommended all countries to use both maternal vaccine and a monoclonal antibo ...

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all ...

Adults with RSV-associated acute respiratory infection face a 2.7-fold higher risk for death within one year, according to a ...

Patients with respiratory syncytial virus (RSV) hospitalization have increased odds of any acute cardiovascular event ...

Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs Late-breaking data show infant respiratory syncytial virus (RSV) ...

Universal immunisation with nirsevimab significantly reduces hospitalizations and paediatric intensive care admissions for ...

The new three-illness dashboard includes a history of outbreaks for any or all of the three respiratory illnesses. It ...

A statewide immunization program for infants against respiratory syncytial virus (RSV), which began in 2024, has already ...